The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction

被引：2
|
作者：
Svilaas, T [1 ]
van der Horst, ICC [1 ]
Zijlstra, F [1 ]
机构：
[1] Univ Groningen, Med Ctr, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 23期
关键词：
D O I：
10.1093/eurheartj/ehi553
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2479 / 2481
页数：3
相关论文
共 50 条
  • [31] Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
    Petroni, Thibaut
    Zaman, Azfar
    Georges, Jean-Louis
    Hammoudi, Nadjib
    Berman, Emmanuel
    Segev, Amit
    Juliard, Jean-Michel
    Barthelemy, Olivier
    Silvain, Johanne
    Choussat, Remi
    Le Feuvre, Claude
    Helft, Gerard
    [J]. HEART, 2016, 102 (20) : 1648 - 1654
  • [32] Impact of Platelet Glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with acute myocardial infarction treated with primary percutaneous coronary intervention
    Osherov, A.
    Aronson, D.
    Hammerman, H.
    Kapeliovich, M.
    Roguin, A.
    Kerner, A.
    Grenadier, E.
    Markiewicz, W.
    Beyar, R.
    Nikolsky, E.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 137 - 137
  • [33] Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Zeymer, Uwe
    Gitt, Anselm
    Zahn, Ralf
    Juenger, Claus
    Bauer, Timm
    Heer, Tobias
    Koeth, Oliver
    Senges, Jochen
    [J]. EUROINTERVENTION, 2009, 4 (04) : 524 - 528
  • [34] Glycoprotein IIb/IIIa inhibitors and the guidelines for treatment of non-ST-elevation myocardial infarction - Reply
    Peterson, ED
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 927 - 928
  • [35] Synergistic effect of thrombus aspiration and glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention
    Pyxaras, S. A.
    Mangiacapra, F.
    Di Serafino, L.
    Toth, G.
    De Vroey, F.
    Perkan, A.
    De Bruyne, B.
    Salvi, A.
    Sinagra, G.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 549 - 550
  • [36] Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction
    Dobesh, PP
    Kasiar, JB
    [J]. PHARMACOTHERAPY, 2002, 22 (07): : 864 - 888
  • [37] Glycoprotein IIb/IIIa inhibitors: Therapeutic applications in acute ST-segment elevation myocardial infarction
    Campbell, KR
    Cantor, W
    Sketch, M
    Ohman, EM
    [J]. AMERICAN HEART JOURNAL, 2000, 140 (06) : S115 - S124
  • [38] Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction
    Sim, Doo Sun
    Ahn, Youngkeun
    Jeong, Myung Ho
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Seung, Ki Bae
    Park, Seung Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 36B - 36B
  • [39] Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction
    Cannon, CP
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (08) : 561 - 566
  • [40] Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction
    Di Mario, Carlo
    [J]. HEART, 2014, 100 (11) : 823 - 824
12345